SE458118B - Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition - Google Patents

Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition

Info

Publication number
SE458118B
SE458118B SE8202947A SE8202947A SE458118B SE 458118 B SE458118 B SE 458118B SE 8202947 A SE8202947 A SE 8202947A SE 8202947 A SE8202947 A SE 8202947A SE 458118 B SE458118 B SE 458118B
Authority
SE
Sweden
Prior art keywords
methanol
carried out
process according
chondroitin
acid
Prior art date
Application number
SE8202947A
Other languages
English (en)
Swedish (sv)
Other versions
SE8202947L (sv
SE8202947D0 (sv
Inventor
K H Wolf
Original Assignee
Luitpold Werk Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Werk Chem Pharm filed Critical Luitpold Werk Chem Pharm
Publication of SE8202947D0 publication Critical patent/SE8202947D0/xx
Publication of SE8202947L publication Critical patent/SE8202947L/xx
Publication of SE458118B publication Critical patent/SE458118B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8202947A 1981-05-11 1982-05-11 Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition SE458118B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3118588A DE3118588C2 (de) 1981-05-11 1981-05-11 Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung

Publications (3)

Publication Number Publication Date
SE8202947D0 SE8202947D0 (sv) 1982-05-11
SE8202947L SE8202947L (sv) 1982-11-12
SE458118B true SE458118B (sv) 1989-02-27

Family

ID=6131969

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8202947A SE458118B (sv) 1981-05-11 1982-05-11 Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition

Country Status (19)

Country Link
US (1) US4524066A (fi)
JP (1) JPS57192401A (fi)
AT (1) AT387225B (fi)
AU (1) AU552545B2 (fi)
BE (1) BE893097A (fi)
CA (1) CA1207758A (fi)
CH (1) CH650788A5 (fi)
DE (1) DE3118588C2 (fi)
DK (1) DK160317C (fi)
FI (1) FI70416C (fi)
FR (1) FR2505185B1 (fi)
GB (1) GB2098232B (fi)
IE (1) IE53633B1 (fi)
IL (1) IL65743A (fi)
IT (1) IT1157939B (fi)
LU (1) LU84143A1 (fi)
NL (1) NL186638C (fi)
NO (1) NO157147C (fi)
SE (1) SE458118B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
CA1327354C (en) * 1987-03-19 1994-03-01 David Cullis-Hill Anti-inflamatory compounds and compositions
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5519010A (en) * 1989-02-06 1996-05-21 Taiho Pharmaceutical Co., Ltd. Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
ATE138938T1 (de) * 1989-02-06 1996-06-15 Taiho Pharmaceutical Co Ltd Sulfatiertes polysaccharid, dessen pharmazeutisch verträgliche salze, dessen herstellung und medikament, das dieses als wirksstoff enthält
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
IN181358B (fi) * 1995-02-14 1998-05-30 Bioniche Inc
WO2000056298A2 (en) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Treatment of lyme disease with polysulfated glycosaminoglycan formulations
SI1625135T1 (sl) * 2003-02-27 2009-08-31 Glaxo Group Ltd Sestavek natrijevega fondaparinuksa visoke äśistote
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
FR2969618B1 (fr) * 2010-12-28 2014-05-16 Pf Medicament Procede de preparation de chondroitine sulfate de sodium
RU2677330C2 (ru) * 2015-11-20 2019-01-16 Закрытое Акционерное Общество "Фармфирма "Сотекс" Способ приготовления инъекционной формы препарата хондроитина сульфата
WO2024072942A2 (en) 2022-09-29 2024-04-04 Adora Animal Health Corporation Skin penetrating formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (fi) * 1902-12-05
DE870094C (de) * 1950-10-17 1953-03-09 Geigy Ag J R Verfahren zur Herstellung von Polyschwefelsaeureestern des Chondroitins
DE935843C (de) * 1951-07-12 1955-12-01 Hoffmann La Roche Verfahren zur Herstellung eines blutgerinnungshemmenden Mittels
US2767167A (en) * 1953-07-06 1956-10-16 Gen Mills Inc Process of reducing the viscosity of gums
DE968752C (de) * 1954-01-29 1958-03-27 Hoffmann La Roche Verfahren zur Herstellung von Chondroitinpolyschwefelsaeureestern
US2803558A (en) * 1956-06-27 1957-08-20 Commw Color & Chemical Co Method of treating adhesive gums
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
US3174904A (en) * 1963-03-25 1965-03-23 Rexall Drug Chemical Method of purifying sulfated carbohydrates
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
US3454560A (en) * 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
BE857389A (fr) * 1977-08-02 1977-12-01 Marbex Finance Ltd Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000

Also Published As

Publication number Publication date
AT387225B (de) 1988-12-27
DK160317B (da) 1991-02-25
FR2505185A1 (fr) 1982-11-12
DK160317C (da) 1991-08-05
FR2505185B1 (fr) 1986-02-28
SE8202947L (sv) 1982-11-12
FI70416C (fi) 1986-09-19
IT8221189A0 (it) 1982-05-11
NL186638B (nl) 1990-08-16
GB2098232A (en) 1982-11-17
CA1207758A (en) 1986-07-15
FI821651A0 (fi) 1982-05-11
JPS57192401A (en) 1982-11-26
ATA184282A (de) 1988-05-15
IT1157939B (it) 1987-02-18
US4524066A (en) 1985-06-18
AU552545B2 (en) 1986-06-05
NO157147C (no) 1988-01-27
NO157147B (no) 1987-10-19
CH650788A5 (de) 1985-08-15
DE3118588C2 (de) 1983-07-07
IL65743A (en) 1985-09-29
NL186638C (nl) 1991-01-16
IL65743A0 (en) 1982-08-31
DE3118588A1 (de) 1982-12-02
SE8202947D0 (sv) 1982-05-11
GB2098232B (en) 1985-02-13
AU8357382A (en) 1982-11-18
DK211882A (da) 1982-11-12
JPH0261482B2 (fi) 1990-12-20
LU84143A1 (fr) 1982-09-13
FI821651L (fi) 1982-11-12
NO821551L (no) 1982-11-12
FI70416B (fi) 1986-03-27
NL8201873A (nl) 1982-12-01
IE821127L (en) 1982-11-11
IE53633B1 (en) 1989-01-04
BE893097A (fr) 1982-08-30

Similar Documents

Publication Publication Date Title
SE458118B (sv) Foerfarande foer framstaellning av ett injicerbart kondroitinpolysulfat, en produkt som kan erhaallas genom detta foerfarande och en farmaceutisk komposition
AT396930B (de) Aminoxide
US10246524B2 (en) Method for preparing sulfobutyl ether-β-cyclodextrin
CH641432A5 (de) Verfahren zur aufspaltung von racemischer 6-methoxy-alpha-methyl-2-naphthalinessigsaeure in die optischen antipoden.
DE2154277A1 (de) Verfahren zum teilweisen Abbau von Desoxyribonucleinsäure
SK287459B6 (sk) Oligosacharidy, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
DE2653257C2 (fi)
US11306158B1 (en) Method for preparing high-purity sugammadex sodium
DE1900974C3 (de) 2,6-Diphenyl-3-methyl-23-dihydroimidazo [2,1 -b] thiazol, dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
CN1282662C (zh) 不定位甲基化β－环糊精的合成工艺
US11274164B2 (en) Method for the preparation of sulfobutylether beta cyclodextrin sodium
EP0417604A2 (de) Verfahren zur Herstellung von Riboflavin-5'-phosphat bzw. dessen Natriumsalz
DE68910912T2 (de) Herstellung von Pyridazinon.
US20140121369A1 (en) Method for purifying ceftizoxime sodium
DE3922278C2 (de) Verfahren zur herstellung von freiem (epsilon)-polylysin
CN112321751A (zh) 一种高品质依诺肝素钠的精制方法
DE69509822T2 (de) Verfahren zur Herstellung von Ascorbinsäurederivaten
DE2543000A1 (de) Neue derivate des cephalosporins, ihre herstellung und die sie enthaltenden zusammensetzungen
EP0045080B1 (de) Verfahren zur Reinigung von Nicotinsäureamid II
DE2640123C3 (de) Maleinsäuresalz des 2-Phenyl-6-(l-hydroxy-2-tert.-butylaminoäthyl)-4H-pyrido-(3,2-d)-l,3-dioxins, ein Verfahren zur Herstellung desselben sowie ein Verfahren zur Herstellung von 2-Hydroxymethyl-3hydroxy-6-(l -hydroxy-2-tert.-butylaminoäthyD-pyridin
CN110981992B (zh) 一种注射剂用透明质酸的制备方法
CN117645678A (zh) 一种小分子质酸钙、质酸亚铁、质酸锌及其制备方法与应用
RU2240803C1 (ru) Способ получения водного раствора для инфузий
CN115916761A (zh) 利用高纯度四西坦(dota)制取钆特酸葡甲胺的方法及其在制备可注射盖仑制剂中的应用
CN116869931A (zh) 一种高溶解度盐酸胺碘酮注射液及其生产工艺

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8202947-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8202947-1

Format of ref document f/p: F